MGMA report shows value-based contracts account for $30,922 per provider
The Medical Group Management Association released a report looking at the proliferation of value-based contracts and how quality metrics tie-in to revenue.
The report, 2022 MGMA DataDive Practice Operations, shows that revenue from value-based contracts accounted for varying amounts of total medical revenue in 2021 among reporting practices:
• 6.74% in primary care specialties
• 5.54% in surgical specialties
• 14.74% in nonsurgical specialties.
Across all practices, the median revenue amount from value-based contracts was $30,922 per FTE provider, according to MGMA.
Quality reporting measures make up a big part of value-based contracts. MGMA polling earlier in 2022 found that the adoption of quality performance metrics in value-based contracts also is being reflected in updated physician compensation plans, as 42% of medical groups tie some element of quality performance metrics to physician compensation plans.
The following measures were reported by respondents for their value-based contracts:
Prior to the COVID-19 pandemic, MGMA noted there was a very slow growth in the inclusion of quality metrics in compensation plans. About one in four (26%) medical groups tied quality performance to physician compensation in 2016, but by July 2018, the share of groups with quality tied to compensation rose to 36%. A March 2019 poll found that nearly 4 in 10 (38%) of groups had tied quality performance to physician compensation.
These numbers have increased since the pandemic. According to the MGMA, 35% report they have increased the share of compensation tied to quality in the past two years, 62% of medical groups have the same share of compensation tied to quality versus 2019 levels, while only 2% of respondents said they decreased the percentage of compensation tied to quality.
Medical groups use in-house analysts, vendors/software, or both to handle their analytics. The majority (45%) reported they use both in-house analysts and software, while 40% only use in-house analysts, with 15% using only vendors or third-party software.